Literature DB >> 15572046

Genome-wide expression profiling of a cardiac pressure overload model identifies major metabolic and signaling pathway responses.

Roger A Wagner1, Raymond Tabibiazar, Jennifer Powers, Daniel Bernstein, Thomas Quertermous.   

Abstract

Cardiac hypertrophy is a predictor of cardiovascular morbidity and mortality independent of other risk factors. Pressure overload induces the development of left ventricular hypertrophy (LVH) and left atrial enlargement (LAE) in the mammalian heart. To systematically investigate the transcriptional changes, which mediate these processes, we have performed a genome-wide transcriptional profiling of each of the four heart chambers from mice subjected to transverse aortic constriction (TAC). A major new finding of this analysis is that during enlargement the left atrium undergoes radical changes in gene transcription that may play a significant role in pathophysiology. Structural changes in the LA and LV are correlated with significant changes in the transcriptional profile of these chambers, with thousands of differentially expressed known and novel factors. Statistical analysis of the results identified Gene Ontology biological process groups with significant group-wide changes, including angiogenesis, energy pathways, fatty acid oxidation, oxidative phosphorylation, cytoskeletal and matrix reorganization, and G-protein coupled receptor (GPCR) signaling. To facilitate future research, a searchable annotated Internet database has been constructed that allows access to the expression data presented here. Further study of these genes and processes will lead to better understanding of pathways involved in the pathophysiology of the cardiac response to pressure overload.

Entities:  

Mesh:

Year:  2004        PMID: 15572046     DOI: 10.1016/j.yjmcc.2004.09.003

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  18 in total

1.  Panhistone deacetylase inhibitors inhibit proinflammatory signaling pathways to ameliorate interleukin-18-induced cardiac hypertrophy.

Authors:  Gipsy Majumdar; Robert J Rooney; I Maria Johnson; Rajendra Raghow
Journal:  Physiol Genomics       Date:  2011-09-27       Impact factor: 3.107

2.  Interleukin-18 knockout mice display maladaptive cardiac hypertrophy in response to pressure overload.

Authors:  James T Colston; William H Boylston; Marc D Feldman; Chris P Jenkinson; Sam D de la Rosa; Amanda Barton; Rodolfo J Trevino; Gregory L Freeman; Bysani Chandrasekar
Journal:  Biochem Biophys Res Commun       Date:  2007-01-16       Impact factor: 3.575

3.  Cardiac pressure overload hypertrophy is differentially regulated by β-adrenergic receptor subtypes.

Authors:  Mingming Zhao; Giovanni Fajardo; Takashi Urashima; Joshua M Spin; Sara Poorfarahani; Viswanathan Rajagopalan; Diem Huynh; Andrew Connolly; Thomas Quertermous; Daniel Bernstein
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-06-24       Impact factor: 4.733

4.  Propranolol enhances cell cycle-related gene expression in pressure overloaded hearts.

Authors:  Marco Musumeci; Sonia Maccari; Paola Sestili; Michele Signore; Paola Molinari; Caterina Ambrosio; Tonino Stati; William H Colledge; Andrew A Grace; Liviana Catalano; Giuseppe Marano
Journal:  Br J Pharmacol       Date:  2011-12       Impact factor: 8.739

5.  Histopathological study of time course changes in inter-renal aortic banding-induced left ventricular hypertrophy of mice.

Authors:  Hiroyuki Higashiyama; Masaki Sugai; Hirotaka Inoue; Kaori Mizuyachi; Hiroshi Kushida; Satoshi Asano; Mine Kinoshita
Journal:  Int J Exp Pathol       Date:  2007-02       Impact factor: 1.925

6.  Integrated glycoprotein immobilization method for glycopeptide and glycan analysis of cardiac hypertrophy.

Authors:  Shuang Yang; Sumita Mishra; Lijun Chen; Jian-Ying Zhou; Daniel W Chan; Subroto Chatterjee; Hui Zhang
Journal:  Anal Chem       Date:  2015-10-06       Impact factor: 6.986

7.  Reciprocal transcriptional regulation of metabolic and signaling pathways correlates with disease severity in heart failure.

Authors:  Andreas S Barth; Ami Kumordzie; Constantine Frangakis; Kenneth B Margulies; Thomas P Cappola; Gordon F Tomaselli
Journal:  Circ Cardiovasc Genet       Date:  2011-08-09

8.  Gene expression profiling-based identification of CD28 and PI3K as new biomarkers for chronic graft-versus-host disease.

Authors:  Peilong Lai; Jianyu Weng; Zesheng Lu; Rong Guo; Chenwei Luo; Suijing Wu; Wei Ling; Suxia Geng; Xin Du
Journal:  DNA Cell Biol       Date:  2011-06-17       Impact factor: 3.311

9.  Periostin is a novel factor in cardiac remodeling after experimental and clinical unloading of the failing heart.

Authors:  William E Stansfield; Nancy M Andersen; Ru-Hang Tang; Craig H Selzman
Journal:  Ann Thorac Surg       Date:  2009-12       Impact factor: 4.330

10.  Molecular and physiological characterization of RV remodeling in a murine model of pulmonary stenosis.

Authors:  Takashi Urashima; Mingming Zhao; Roger Wagner; Giovanni Fajardo; Sara Farahani; Tom Quertermous; Daniel Bernstein
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-06-27       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.